Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
12/22/2011 | DE10046284B4 Vorrichtung zum Erfassen des frühen Dehn- und Schwindverhaltens von Baustoffen Means for detecting the early expansion and shrinkage behavior of building materials |
12/22/2011 | CA2805720A1 Rotors for immunoassays |
12/22/2011 | CA2805409A1 Pla2g16 as a target for antiviral compounds |
12/22/2011 | CA2805346A1 Method for characterising an agri-food product and device for implementing such a method |
12/22/2011 | CA2802911A1 Methods for direct pcr using a polymeric material as sample carrier |
12/22/2011 | CA2802884A1 Antimicrobial silicone-based wound dressings |
12/22/2011 | CA2802868A1 Methods and systems for generating, validating and using monoclonal antibodies |
12/22/2011 | CA2802857A1 Antibodies to endoplasmin and their use |
12/22/2011 | CA2802762A1 An optical pathogen detection system and quality control materials for use in same |
12/22/2011 | CA2802735A1 Tritiated planar carbon forms |
12/22/2011 | CA2802724A1 Method and system for detecting biological molecules in samples |
12/22/2011 | CA2802723A1 Detection of epha3 as a marker of the presence of a solid tumor |
12/22/2011 | CA2802719A1 Isotopic labeling for the measurement of global protein levels and turnover in vivo |
12/22/2011 | CA2802386A1 Magnetic beads for reducing leukocyte interference in immunoassays |
12/22/2011 | CA2802322A1 System and method for determining the phase envelope of a gas condensate |
12/22/2011 | CA2802115A1 A container, a closure for a container, and a base for a container |
12/22/2011 | CA2802087A1 A compendium of ready-built stem cell models for interrogation of biological response |
12/22/2011 | CA2801210A1 Anti-gd2 antibodies |
12/22/2011 | CA2800887A1 Non covalent molecular structure, device comprising the same and its use for the detection of a lectin |
12/22/2011 | CA2800458A1 Prediction and recognition of acute kidney injury after surgery |
12/22/2011 | CA2798742A1 Biomarkers for the treatment of psoriasis |
12/22/2011 | CA2797926A1 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof |
12/22/2011 | CA2773759A1 Non-invasive compressibility and in situ density testing of a fluid sample in a sealed chamber |
12/21/2011 | EP2397858A1 Method and apparatus for analyzing vitamin E in lipoproteins |
12/21/2011 | EP2397857A1 Method for assaying physiological substance of biological origin and assay device therefor |
12/21/2011 | EP2397856A2 Methods for detecting a mycobacterium tuberculosis infection |
12/21/2011 | EP2397855A2 Methods for detecting a mycobacterium tuberculosis infection |
12/21/2011 | EP2397854A2 Methods for detecting a mycobacterium tuberculosis infection |
12/21/2011 | EP2397853A2 Methods for detecting a mycobacterium tuberculosis infection |
12/21/2011 | EP2397852A2 Methods for detecting a mycobacterium tuberculosis infection |
12/21/2011 | EP2397851A1 Method for selecting mevalonate synthesis modulators using cells derived from pluripotent human cells |
12/21/2011 | EP2397850A2 Open-type groove channel chip |
12/21/2011 | EP2397849A1 Method for measuring the alkali-silica reaction in concrete by means of continuous acoustic emission analysis and ultrasound measurement |
12/21/2011 | EP2397848A1 Continuous strain measurement when testing the influence of the alkali-silica reaction on microstructural changes in concrete |
12/21/2011 | EP2397844A1 Evanescent field sensor, sensing layer for use in such a sensor and gel for use as such a sensing layer |
12/21/2011 | EP2397838A1 Gas sensor and method for measuring humidity and the concentration of carbon dioxide |
12/21/2011 | EP2397834A2 Measuring probes for measuring and sampling with a metal melt |
12/21/2011 | EP2397566A1 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
12/21/2011 | EP2397562A2 Target substance detection method using aptamer |
12/21/2011 | EP2397550A2 Nucleic acid aptamer which specifically binds to bisphenol a |
12/21/2011 | EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes |
12/21/2011 | EP2397546A1 Method for predicting iga nephropathy and method for screening iga nephropathy patient |
12/21/2011 | EP2397499A2 Human anti-B7RP1 neutralizing antibodies |
12/21/2011 | EP2397498A2 Human anti-B7RP1 neutralizing antibodies |
12/21/2011 | EP2397497A2 Human anti-B7RP1 neutralizing antibodies |
12/21/2011 | EP2397496A2 Human anti-B7RP1 neutralizing antibodies |
12/21/2011 | EP2397494A1 Human antibodies that bind human TNFalpha |
12/21/2011 | EP2397156A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1)pathway |
12/21/2011 | EP2397155A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway |
12/21/2011 | EP2396663A1 Methods of assaying for tetrahydrocannabinol |
12/21/2011 | EP2396662A2 Method for evaluating risk in multiple sclerosis |
12/21/2011 | EP2396661A1 Molecular profiling of tumors |
12/21/2011 | EP2396660A2 Prediction of response to platinum-based therapy |
12/21/2011 | EP2396659A1 Rbm3 protein in testicular cancer diagnostics and prognostics |
12/21/2011 | EP2396658A1 Assay for detection of adrenal tumour |
12/21/2011 | EP2396657A1 Rbm3 as a marker for malignant melanoma prognosis |
12/21/2011 | EP2396656A1 Enzymatic assay for the quantitative determination of phospholipase a1 or a2 activity in a sample |
12/21/2011 | EP2396655A1 DEVICE FOR SEROLOGICALLY DETECTING YERSINIA INFECTIONS AND/OR SECONDARY DISEASES THEREOF AND USE OF THE PROTEINS MyfA AND PsaA OF Y. ENTEROCOLITICA AND Y. PSEUDOTUBERCULOSIS AS RECOMBINANT ANTIGENS |
12/21/2011 | EP2396654A2 System, method and device for tissue-based diagnosis |
12/21/2011 | EP2396653A1 Devices and methods for observing the cell division |
12/21/2011 | EP2396652A1 Antibody to cytolethal distending toxin of campylobacter jejuni |
12/21/2011 | EP2396650A1 Sensor element of a gas sensor and method for operating the same |
12/21/2011 | EP2396649A1 A construction unit, comprising a light detector, and a process to assemble such construction unit to a carrier, such as printed circuit card |
12/21/2011 | EP2396647A1 Probing electrode/solution interfaces |
12/21/2011 | EP2396420A1 Enzymatic assay for the quantitative determination of phospholipase a1 or a2 activity in a sample |
12/21/2011 | EP2396419A1 Method of determining hypoxia |
12/21/2011 | EP2396418A1 Methods for the detection of fatty-acylated proteins |
12/21/2011 | EP2396417A1 Polymeric immobilization matrix for live-cell biosensors |
12/21/2011 | EP2396349A1 Customized molecularly imprinted polymer (mip) units |
12/21/2011 | EP2396346A1 Rbm3 protein in colorectal cancer prognostics |
12/21/2011 | EP2396342A2 Mutant ros expression in human cancer |
12/21/2011 | EP2396113A1 Diagnostic test strip for liquid samples |
12/21/2011 | EP2396084A1 Anti-mst1r antibodies and uses thereof |
12/21/2011 | EP2396024A1 Use of antisecretory factors (af) for optimizing cellular uptake |
12/21/2011 | EP2395915A1 Breath analysis |
12/21/2011 | EP2171465B1 Soluble cadherin 17 for the diagnosis and risk stratification of cancer and tumour of the gastrointestinal tract |
12/21/2011 | EP2171091B1 Identification of ectopic pregnancies |
12/21/2011 | EP2156178B1 Methods for enhanced analysis of acoustic field focused cells and particles |
12/21/2011 | EP2122357B1 Digalactolipidic antigen exposed on the surface of apicomplex parasites, and diagnostic and therapeutic use thereof |
12/21/2011 | EP2115159B1 Assays for modulators of parkin activity using novel substrates |
12/21/2011 | EP2087352B1 Sequential optical detection on an array of spaced-apart test zones |
12/21/2011 | EP2013616B1 Method for the detection of hydrogen in steel |
12/21/2011 | EP2012123B1 Marker for predicting graft-versus-host disease and utilization of the same |
12/21/2011 | EP1996940B1 Detection of cancer by elevated levels of bcl-2 |
12/21/2011 | EP1953238B1 Method for screening of substances using GPR40 and secretory phospholipase A2 |
12/21/2011 | EP1800124B1 Image based quantitation of molecular translocation |
12/21/2011 | EP1783496B1 Method of analyzing protein structural affinity relationship |
12/21/2011 | EP1765863B1 Peptide-based compounds |
12/21/2011 | EP1692161B1 Chimeric chemokine receptor polypeptides |
12/21/2011 | EP1664769B1 Assay for detecting atrial and brain natriuretic peptide prohormones |
12/21/2011 | EP1539791B1 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
12/21/2011 | EP1495134B1 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients |
12/21/2011 | EP1490672B1 An electrical condition monitoring method for polymers |
12/21/2011 | EP1483578B1 Artificial receptors, building blocks, and methods |
12/21/2011 | EP1461078B1 A PEPTIDE-BASED FLUORESCENCE POLARIZATION ASSAY FOR DETECTION OF ANTIBODIES TO i MYCOBACTERIUM BOVIS /i |
12/21/2011 | EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
12/21/2011 | EP1386152B1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
12/21/2011 | EP1360490B1 Nucleic-acid programmable protein arrays |
12/21/2011 | EP1266003B1 Kcnb: a potassium channel protein |
12/21/2011 | EP1244913B1 Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens |